10. The Biomarkers That Matter: What We’re Building, Learning, and Where We’re Headed

In this episode of Vitality Vision, host Greg Bennett sits down with Voloridge Health President Barry Miller and CEO/Chief Science Officer David Vogel to reflect on a pivotal moment for the company — from a standout presence at the Eudemonia Longevity Summit to the road ahead in 2026. 

They break down the five biomarkers every health-conscious person should know — Cystatin C, HgbA1c, hsCRP, GGT, and ApoB — and why these often-overlooked metrics may be more powerful than the ones we’ve been trained to track.

 Along the way, they share how it felt to introduce Voloridge Health to the broader wellness world, what resonated most with attendees, and why this felt like a true "coming out moment" for the company.

The conversation also explores Voloridge’s product evolution, scientific breakthroughs, and bigger mission: to shift healthcare from reactive to predictive, and give people the tools to live with energy, clarity, and purpose.

Whether you're an early adopter of wearables and bloodwork, or just starting to explore your own health data, this episode delivers practical insight and big-picture perspective on where proactive health is going next.